Clinical Trial Update: Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of fludarabine with a monoclonal antibody for untreated B-cell chronic lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Fludarabine (Fludarabine)
• Monoclonal antibody therapy

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia | Phase 2 | Status: COMPLETED